Member of the board since 2020
Eva Sjökvist Saershas a MSc Pharm and a PhD Pharm from the Faculty of Pharmacy, University of Uppsala. She has a broad experience from R&D from Astra/AstraZeneca in various management positions. For more than 15 years Eva was the head and CEO of APL (Apotek Produktion & Laboratorier AB), a pharmaceutical company with more than 500 employees and a revenue of SEK 1,4 billion. APL has the commission from the state to develop and manufacture pharmaceuticals for patients with special needs. APL is also a CDMO (Contract Development and Manufacturing Organisation) that supports life science companies with drug development and manufacturing services. Eva is today active in boards in life science as a board member in Dicot (chairman of the board), Alligator Bioscience AB, Bluefish Pharmaceuticals AB and Empowered Applications AB. Eva is the chairman of Swelife, a strategic innovation program appointed by the government. She is the former chairman of the Swedish Society of Pharmaceutical Sciences (Apotekarsocieteten), former vice chairman of SwedenBIO, the national association of the life science industry, and former boardmember of Karo Pharma AB, Recipharm AB, IDL Biotech AB and KIHAB (Karolinska Institutet Holding AB).
.
Holdings : 0 A-shares, 7 375 B-shares and 40 000 warrants.
Independent in relation to the Company and its management and the Company’s major shareholders.